Skip to main content
Log in

Differential course of HIV-1 infection and apolipoprotein E polymorphism

  • Research Article
  • Published:
Central European Journal of Medicine

Abstract

We studied the course of infection with human immunodeficiency virus type 1 (HIV-1) in relation to apolipoprotein E (APOE) polymorphism found for 209 Italians treated at Infectious Disease Clinics in Rome and Modena. Clinically, patients were classified into four groups according to the yearly rate of decline in CD4+ cell count (LTNP: long-term non-progression; SLOW, ’NORMAL’ or RAPID). Patients at both extremes of the clinical spectrum, i.e. those who rapidly progressed to AIDS and those with stable high CD4 cell counts, had few APOE ɛ4 and ɛ2 alleles (P = 0.04). Detailed clinical information was then used to construct four model-based clinical profiles using grade-of-membership analysis (GoM), predictive of APOE genotypic frequencies: 1. The clinical profile associated with good long-term prognosis lacked ɛ2 (P=0.01); 2. Disease progression to AIDS was associated with ɛ4 and ɛ2, most evident for zidovudine-lamivudine regimens without a protease inhibitor (P = 0.03); and, 3. AIDS patients had low ɛ4 and ɛ2 frequencies, consistent with a high mortality rate among ɛ4+ and ɛ2+ AIDS patients. These findings suggest allele-specific immunomodulatory effects involving inherited APOE isoform important enough to alter the clinical course of HIV infection and, possibly, drug efficacy. They imply a connection between lipid metabolism and immunity potentially relevant to common disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R.W. Mahley: “Apolipoprotein E: cholesterol transport protein with expanding role in cell biology”, Science, Vol. 240 (1988), pp. 622–630.

    Article  PubMed  CAS  Google Scholar 

  2. E.M. Avila, G. Holdsworth, N. Sasaki, R.L. Jackson and J.A. Harmony: “Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells”, J. Biol. Chem., Vol. 257, (1982), pp. 5900–5909.

    PubMed  CAS  Google Scholar 

  3. M.G. Pepe and L.K. Curtiss: “Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In”, J. Immunol., Vol. 136, (1986), pp. 3716–3723.

    PubMed  CAS  Google Scholar 

  4. L.K. Curtiss and T.S. Edgington: “The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content”, J. Immunol., Vol 126, (1981), pp. 1382–1386.

    PubMed  CAS  Google Scholar 

  5. R.A. Terkeltaub, C.A. Dyer, J. Martin and L.K. Curtiss: “Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo”, J. Clin. Invest., Vol. 87, (1991), pp. 20–26.

    Article  PubMed  CAS  Google Scholar 

  6. N. de Bont, P.N. Demacker, B.J. Kullberg, J.W. van der Meer and A.F. Stalenhoef: “Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae”, Eur. J. Clin. Invest., Vol. 30, (2000), pp. 818–822.

    Article  PubMed  Google Scholar 

  7. S.E. Roselaar and A. Daugherty: “Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo”, J. Lipid. Res., Vol 39, (1998), pp. 1740–1743.

    PubMed  CAS  Google Scholar 

  8. D.T. Laskowitz, D.M. Lee, D. Schmechel and H.F. Staats: “Altered immune responses in apolipoprotein E-deficient mice”, J. Lipid. Res., Vol. 41, (2000), pp. 613–620.

    PubMed  CAS  Google Scholar 

  9. B. Ludewig, M. Jäggi, T. Dumrese, K. Brduscha-Riem, B. Odermatt, H. Hengartner and R.M. Zinkernagel: “Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of antiviral cytotoxic T cell responses”, J. Immunol., Vol. 166, (2001), pp. 3369–3376.

    PubMed  CAS  Google Scholar 

  10. T. Kuusi, M.S. Nieminen, C. Ehnholm, H. Yki-Järvinen, M. Valle, E.A. Nikkilä and M.R. Taskinen: “Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients”, Arteriosclerosis, Vol. 9, (1989), pp. 237–241.

    PubMed  CAS  Google Scholar 

  11. G. Utermann, A. Hardewig and F. Zimmer: “Apolipoprotein E phenotypes in patients with myocardial infarction”, Hum. Genet., Vol. 65, (1984), pp. 237–241.

    Article  PubMed  CAS  Google Scholar 

  12. E.H. Corder, H. Basun, L. Fratiglioni, Z. Guo, L. Lannfelt, M. Viitanen, L.S. Corder, K.G. Manton and B. Winblad: “Inherited frailty. ApoE alleles determine survival after a diagnosis of heart disease or stroke at ages 85+”, Ann. N. Y. Acad. Sci., Vol. 908, (2000), pp. 295–298.

    Article  PubMed  CAS  Google Scholar 

  13. A.M. Saunders, W.J. Strittmatter, D. Schmechel, P.H. George-Hyslop, M.A. Pericak-Vance, S.H. Joo, B.L. Rosi, J.F. Gusella, D.R. Crapper-MacLachlan and M.J. Alberts: “Association of apolipoprotein E allele e4 with late onset familial and sporadic Alzheimer’s disease”, Neurology, Vol. 43, (1993), pp. 1467–1472.

    PubMed  CAS  Google Scholar 

  14. W.J. Strittmatter, K.H. Weisgraber, D.Y. Huang, L.M. Dong, G.S. Salvesen, M. Pericak-Vance, D. Schmechel, A.M. Saunders, D. Goldgaber and A.D. Roses: “Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 3 allele in late-onset familial Alzheimer disease”, Proc. Natl. Acad. Sci. USA, Vol. 90, (1993), pp. 1977–1981.

    Article  PubMed  CAS  Google Scholar 

  15. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines and M.A. Pericak-Vance: “Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families”, Science, Vol. 261, (1993), pp. 921–923.

    Article  PubMed  CAS  Google Scholar 

  16. C. Ballerini, D. Campani, G. Rombola, B. Gran, B. Nacmias, M.P. Amato, G. Siracusa, L. Bartolozzi, S. Sorbi and L. Massacesi: “Association of apolipoprotein E polymorphism to clinical heterogeneity of multiple sclerosis”, Neurosci. Lett., Vol. 296, (2000), pp. 174–176.

    Article  PubMed  CAS  Google Scholar 

  17. T. Masterman, J. Hillert, L. Lannfelt and E.H. Corder: “The 4 allele for APOE doubles the risk of poor long-term prognosis in multiple sclerosis”, Am. J. Hum. Genet., Vol. 67, (2000), pp. S1957.

    Google Scholar 

  18. J. Chapman, S. Vinokurov, A. Achiron, D.M. Karussis, K. Mitosek-Szewczyk, M. Birnbaum, D.M. Michaelson and A.D. Korczyn: “APOE genotype is a major predictor of long-term progression of disability in MS”, Neurology, Vol. 56, (2001), pp. 312–316.

    PubMed  CAS  Google Scholar 

  19. H. Akiyama, S. Barger, S. Barnum, B. Bradt, J. Bauer, G.M. Cole, N.R. Cooper, P. Eikelenboom, M. Emmerling, B.L. Fiebich, C.E. Finch, S. Frautschy, W.S. Griffin, H. Hampel, M. Hull, G. Landreth, L. Lue, R. Mrak, I.R. Mackenzie, P.L. McGeer, M.K. O’Banion, J. Pachter, G. Pasinetti, C. Plata-Salaman, J. Rogers, R. Rydel, Y. Shen, W. Streit, R. Strohmeyer, I. Tooyoma, F.L. Van Muiswinkel, R. Veerhuis, D. Walker, S. Webster, B. Wegrzyniak, G. Wenk and T. Wyss-Coray: “Inflammation and Alzheimer’s disease”, Neurobiol. Aging, Vol. 21, (2000), pp. 383–421.

    Article  PubMed  CAS  Google Scholar 

  20. D.T. Laskowitz, A.D. Thekdi, S.D. Thekdi, S.K. Han, J.K. Myers, S.V. Pizzo and E.R. Bennett: “Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides”, Exp. Neurol., Vol. 167, (2001), pp. 74–85.

    Article  PubMed  CAS  Google Scholar 

  21. J.R. Lynch, D. Morgan, J. Mance, W.D. Matthew and D.T. Laskowitz: “Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response”, J. Neuroimmunol., Vol. 114, (2001), pp. 107–113.

    Article  PubMed  CAS  Google Scholar 

  22. R.F. Itzhaki, W.R. Lin, D. Shang, G.K. Wilcock, B. Faragher and G.A. Jamieson: “Herpes simplex virus type 1 in brain and risk for Alzheimer’s disease”, Lancet, Vol. 349, (1997), pp. 241–244.

    Article  PubMed  CAS  Google Scholar 

  23. S. Sorbi, B. Nacmias, S. Piacentini, A. Repice, S. Latorraca, P. Forleo and L. Amaducci: “ApoE as a prognostic factor for post-traumatic coma”, Nat. Med., Vol. 1, (1995), pp. 852.

    Article  PubMed  CAS  Google Scholar 

  24. E.H. Corder, K. Robertson, L. Lannfelt, N. Bogdanovic, G. Eggertsen, J. Wilkins, C. Hall: “HIV-infected subjects who carry the E4 allele for APOE have excess dementia and peripheral neuropathy”, Nat. Med., Vol. 4, (1998), pp. 1182–1184.

    Article  PubMed  CAS  Google Scholar 

  25. Y. Liu, M. Jones, C.M. Hingtgen, G. Bu, N. Laribee, R.E. Tanzi, R.D. Moir, A. Nath and J.J. He: “Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands”, Nat. Med., Vol. 6, (2000), pp. 1380–1387.

    Article  PubMed  CAS  Google Scholar 

  26. C. Grunfeld: “Abnormalities of apolipoprotein E in the acquired immunodeficiency syndrome”, J. Clin. Endocrinol. Metab., Vol. 82, (1997), pp. 3734–3740.

    Article  PubMed  CAS  Google Scholar 

  27. G. Carrieri, M. Bonafe, M. De Luca, G. Rose, O. Varcasia, A. Bruni, R. Maletta, B. Nacmias, S. Sorbi, F. Corsonello, E. Feraco, K.F. Andreev, A.I. Yashin, C. Franceschi and G. De Benedictis: “Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer’s disease”, Hum. Genet., Vol. 108, (2001), pp. 194–198.

    Article  PubMed  CAS  Google Scholar 

  28. E. Girardi, A. Sampaolesi, M. Gentile, G. Nurra and G. Ippolito: “Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy”, J. Acquir. Immune Defic. Syndr., Vol. 25, (2000), pp. 71–76.

    Article  PubMed  CAS  Google Scholar 

  29. O. Dunlop, A.K. Goplen, K. Liestol, B. Myrvang, H. Rootwelt, B. Christophersen, E.A. Kvittingen and J. Maehlen: “HIV dementia and apolipoprotein E”, Acta Neurol. Scand., Vol. 95, (1997), pp. 315–318.

    Article  PubMed  CAS  Google Scholar 

  30. X. Gao, G.W. Nelson, P. Karacki, M.P. Martin, J. Phair, R. Kaslow, J.J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, S.J. O’Brien and M. Carrington: “Effect of a single amino acid change in MHC class 1 molecutes on the rate of progression to AIDS”, N. Engl. J. Med., Vol. 344, (2001), pp. 1668–1675.

    Article  PubMed  CAS  Google Scholar 

  31. R.K. Lister, M. Youle, D.R. Nair, A.F. Winder and M.H.A. Rustin: “Latent dysbetalipoproteinaemia precipitated by HIV-protease inhibitors”, Lancet, Vol. 353, (1999), pp. 1678.

    Article  PubMed  CAS  Google Scholar 

  32. E. Bonnet, J.B. Ruidavets, J. Tuech, J. Ferrieres, X. Collet, J. Fauvel, P. Massip and B. Perret: “Apoprotein C-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy”, J. Clin. Endocrinol. Metab., Vol. 86, (2001), pp. 296–302.

    Article  PubMed  CAS  Google Scholar 

  33. L.U. Gerdes, C. Gerdes, K. Kervinen, M. Savolainen, I.C. Klausen, P.S. Hansen, Y.A. Kesäniemi and O. Faergeman: “The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction: a substudy of the Scandinavian simvastatin survival study”, Circulation, Vol. 101, (2000), pp. 1366–1371.

    PubMed  CAS  Google Scholar 

  34. J.E. Hixson and D.T. Vernier: “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I”, J. Lipid Res., Vol. 31, (1990), pp. 545–548.

    PubMed  CAS  Google Scholar 

  35. Grade of Membership Software: Center for Demographic Studies, Duke University, Durham, NC (1987).

    Google Scholar 

  36. K.G. Manton, M.A. Woodbury and H.D. Tolley: Statistical Applications Using Fuzzy Sets, John Wiley & Sons, New York (1994).

    Google Scholar 

  37. H. Akaike: “Information theory and an extension of the maximum likelihood principle”, In: Proc. Second Internat. Symp. on Information Theory., Akademiai Kiado, Budapest (1972), pp. 267–281.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elizabeth H. Corder.

About this article

Cite this article

Corder, E.H., Galeazzi, L., Franceschi, C. et al. Differential course of HIV-1 infection and apolipoprotein E polymorphism. cent.eur.j.med 2, 404–416 (2007). https://doi.org/10.2478/s11536-007-0039-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11536-007-0039-x

Keywords

Navigation